Fourneau

Fourneau is a Paris-based biotechnology company dedicated to the discovery of novel small molecule therapeutics for challenging biological targets. The company integrates advanced machine learning algorithms with high-throughput automated experimental platforms to accelerate the medicinal chemistry cycle. By focusing on "undruggable" proteins, Fourneau aims to develop first-in-class treatments across various therapeutic areas, including oncology and inflammatory diseases. The company's approach honors the legacy of Ernest Fourneau, a pioneer in medicinal chemistry, by applying modern computational tools to classical drug discovery challenges.